In addition to their value for diagnostic and monitoring purposes, elevated levels of CEA and CA15-3 at the time of systemic recurrence of breast cancer are significantly associated with patient prognosis [3, 4]. The gene discussed is CEACAM5; the disease is breast carcinoma.